Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
ARS Pharmaceuticals Inc (NASDAQ: SPRY) closed the day trading at $14.14 up 2.69% from the previous closing price of $13.77. In other words, the price has increased by $2.69 from its previous closing price. On the day, 0.99 million shares were traded. SPRY stock price reached its highest trading level at $14.27 during the session, while it also had its lowest trading level at $13.845.
Ratios:
For a better understanding of SPRY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 106.89. For the most recent quarter (mrq), Quick Ratio is recorded 14.04 and its Current Ratio is at 14.26. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 07, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $30.
On February 10, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 07 ’25 when Shawver Laura sold 50,002 shares for $12.30 per share. The transaction valued at 615,075 led to the insider holds 210,346 shares of the business.
Shawver Laura bought 50,002 shares of SPRY for $615,051 on Apr 07 ’25. On Mar 20 ’25, another insider, Karas Eric, who serves as the Chief Commercial Officer of the company, sold 10,000 shares for $14.00 each. As a result, the insider received 140,000 and left with 7,696 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1387414016 and an Enterprise Value of 1142817024. As of this moment, ARS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 184.35. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.19. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.56 while its Price-to-Book (P/B) ratio in mrq is 5.39. Its current Enterprise Value per Revenue stands at 12.819 whereas that against EBITDA is -380.432.
Stock Price History:
The Beta on a monthly basis for SPRY is 0.83, which has changed by 0.6252874 over the last 52 weeks, in comparison to a change of 0.097913146 over the same period for the S&P500. Over the past 52 weeks, SPRY has reached a high of $18.51, while it has fallen to a 52-week low of $7.55. The 50-Day Moving Average of the stock is 13.40%, while the 200-Day Moving Average is calculated to be 9.73%.
Shares Statistics:
Over the past 3-months, SPRY traded about 1.68M shares per day on average, while over the past 10 days, SPRY traded about 1300160 shares per day. A total of 97.95M shares are outstanding, with a floating share count of 56.04M. Insiders hold about 42.88% of the company’s shares, while institutions hold 51.16% stake in the company. Shares short for SPRY as of 1744675200 were 16461184 with a Short Ratio of 9.79, compared to 1741910400 on 19429266. Therefore, it implies a Short% of Shares Outstanding of 16461184 and a Short% of Float of 31.280002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
